Cholestasis, bronchopulmonary dysplasia, and lipid profile in preterm infants receiving MCT/ω-3-PUFA-containing or soybean-based lipid emulsions

Nutrition in Clinical Practice

Volumn 27, Issue 6, 2012, Pages 817-824

  Skouroliakou, Maria ^a   Konstantinou, Dimitris ^b   Agakidis, Charalampos ^c   Delikou, Natalia ^c   Koutri, Katerina ^b   Antoniadi, Marina ^b   Karagiozoglou Lampoudi, Thomais ^c  

^a HAROKOPIO UNIVERSITY   (Greece)

^b IASO   (Greece)

^c ALEXANDER TECHNOLOGICAL EDUCATIONAL INSTITUTE OF THESSALONIKI   (Greece)

Author keywords

alkaline phosphatase; fat emulsions, intravenous; fatty acids, omega 3; fatty acids, omega 6; hyperbilirubinemia; infant, newborn; lipoproteins; liver diseases; parenteral nutrition

Indexed keywords

ALKALINE PHOSPHATASE; AMINO ACID; BILIRUBIN; CALCIUM; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTRALIPID; LIPID; LIPID EMULSION; MEDIUM CHAIN TRIACYLGLYCEROL; OMEGA 3 FATTY ACID; PHOSPHATE; TRIACYLGLYCEROL;

ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CHOLESTASIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; HUMAN; INCIDENCE; INFANT; LIPOPROTEIN BLOOD LEVEL; LOW BIRTH WEIGHT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PARENTERAL NUTRITION; PHOSPHATE BLOOD LEVEL; PREMATURITY; SINGLE BLIND PROCEDURE; SOYBEAN; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; VERY LOW BIRTH WEIGHT;

BILIRUBIN; BRONCHOPULMONARY DYSPLASIA; CHOLESTASIS; EMULSIONS; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, OMEGA-3; HUMANS; INCIDENCE; INFANT; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; LIPIDS; LOGISTIC MODELS; OXIDATIVE STRESS; PARENTERAL NUTRITION; PHOSPHOLIPIDS; PROSPECTIVE STUDIES; SOYBEAN OIL; TRIGLYCERIDES;

GLYCINE MAX;

EID: 84868690009     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533612454547     Document Type: Article

References (43)

1. Cober MP, Teitelbaum DH. Prevention of parenteral nutrition-associated liver disease: lipid minimization. Curr Opin Organ Transplant. 2010 ; 15: 330-333
2. Colomb V, Jobert-Giraud A, Lacaille F, Goulet O, Fournet JC, Ricour C. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenteral Enteral Nutr. 2000 ; 24: 345-350
3. Levene MI, Batisti O, Wigglesworth JS, et al. A prospective study of intrapulmonary fat accumulation in the newborn lung following intralipid infusion. Acta Paediatr Scand. 1984 ; 73: 454-460
4. Hammerman C, Aramburo MJ. Decreased lipid intake reduces morbidity in sick premature neonates. J Pediatr. 1988 ; 113: 1083-1088
5. Kelly DA. Preventing parenteral nutrition liver disease. Early Hum Dev. 2010 ; 86: 683-687
6. de Meijer VE, Gura KM, Le HD, Meisel JA, Puder M. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience. JPEN J Parenter Enteral Nutr. 2009 ; 33: 541-547
7. Fallon EM, Le HD, Puder M. Prevention of parenteral nutrition-associated liver disease: role of omega-3 fish oil. Curr Opin Organ Transplant. 2010 ; 15: 334-340
8. Hayashi N, Tashiro T, Yamamori H, et al. Effects of intravenous ω-3 and ω-6 fat emulsion on cytokine production and delayed type hypersensitivity in burned rats receiving total parenteral nutrition. JPEN J Parenter Enteral Nutr. 1998 ; 22: 363-367
9. Wachtler P, Konig W, Senkal M, Kemen M, Köller M. Influence of a total parenteral nutrition enriched with ω-3 fatty acids on leukotriene synthesis of peripheral leukocytes and systemic cytokine levels in patients with major surgery. J Trauma. 1997 ; 42: 191-198
10. Deshpande G, Simmer K. Lipids for parenteral nutrition in neonates. Curr Opin Clin Nutr Metab Care. 2011 ; 14: 145-150
11. Calder CP, Jensen GL, Koletzko BV, Singer P, Wanten GJA. Lipid emulsions in parenteral nutrition of intensive care patients: current thinking and future directions. Intensive Care Med. 2010 ; 36: 735-749
12. Gien J, Kinsella JP. Pathogenesis and treatment of bronchopulmonary dysplasia. Curr Opin Pediatr. 2011 ; 23: 305-313
13. Wright CJ, Kirpalani H. Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?. Pediatrics. 2011 ; 128: 111-126
14. Ulrich H, Pastores SM, Katz DP, Kvetan V. Parenteral use of medium-chain triglycerides: a reappraisal. Nutrition. 1996 ; 12: 231-238
15. Hagi A, Nakayama M, Shinzaki W, Haji S, Ohyanagi H. Effects of the ω-6:ω-3 fatty acid ratio of fat emulsions on the fatty acid composition in cell membranes and the anti-inflammatory action. JPEN J Parenter Enteral Nutr. 2010 ; 34: 263-270
16. Singer P, Shapiro H, Theilla M, Anbar R, Singer J, Cohen J. Antiinflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective. Intensive Care Med. 2008 ; 34: 1580-1592
17. Senkal M, Geier B, Hannemann M, Deska T, Linseisen J, Wolfram G, Adolph M. Supplementation of omega-3 fatty acids in parenteral nutrition beneficially alters phospholipid fatty acid pattern. JPEN J Parenter Enteral Nutr. 2007 ; 31: 12-17
18. Bo Chen B, Zhou Y, Yang P, Wan H-w, Wu X-T. Safety and efficacy of fish oil-enriched parenteral nutrition regimen on postoperative patients undergoing major abdominal surgery: a meta-analysis of randomized controlled trials. JPEN J Parenter Enteral Nutr. 2010 ; 34: 387-394
19. Grimm H, Mertes N, Goeters C, et al. Improved fatty acid and leukotriene pattern with a novel lipid emulsion in surgical patients. Eur J Nutr. 2006 ; 45: 55-60
20. Wichmann MW, Thul P, Czarnetzki HD, Morlion BJ, Kemen M, Jauch KW. Evaluation of clinical safety and beneficial effects of a fish oil containing lipid emulsion (Lipoplus, MLF541): data from a prospective, randomized, multicenter trial. Crit Care Med. 2007 ; 35: 700-706
21. Skouroliakou M, Konstantinou D, Koutri K, et al. A double-blind, randomized clinical trial of the effect of x-3 fatty acids on the oxidative stress of preterm neonates fed through parenteral nutrition. Eur J Clin Nutr. 2010 ; 64: 940-947
22. Rollins MD, Scaife ER, Jackson WD, Meyers RL, Mulroy CW, Book LS. Elimination of soybean lipid emulsion in parenteral nutrition and supplementation with enteral fish oil improve cholestasis in infants with short bowel syndrome. Nutr Clin Pract. 2010 ; 25: 199-204
23. Puder M, Valim C, Meisel JA, et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg. 2009 ; 250: 395-402
24. Driscoll DF, Bistrian BR, Demmelmair H, Koletzko B. Pharmaceutical and clinical aspects of parenteral lipid emulsions in neonatology. Clin Nutr. 2008 ; 27: 497-503
25. Skouloliakou M, Konstantinou D, Papasarantopoulos P, Matthaiou Ch. Computer assisted total parenteral nutrition for preterm and sick term neonates. Pharm World Sci. 2005 ; 27: 305-310
26. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001 ; 163: 1723-1729
27. Zambrano E, El-Hennawy M, Ehrenkranz RA, Zelterman D, Reyes-Múgica M. Total parenteral nutrition induced liver pathology: an autopsy series of 24 newborn cases. Pediatr Dev Pathol. 2004 ; 7: 425-432
28. de Meijer VE, Gura KM, Meisel JA, Le HD, Puder M. Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease. Arch Surg. 2010 ; 145: 547-551
29. Gura KM, Lee S, Valim C, et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics. 2008 ; 121: e678 - e686
30. Diamond IR, Sterescu A, Pencharz PB, Kim JH, Wales PW. Changing the paradigm: Omegaven for the treatment of liver failure in pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr. 2009 ; 48: 209-215
31. Cheung HM, Lam HS, Tam YH, Lee KH, Ng PC. Rescue treatment of infants with intestinal failure and parenteral nutrition-associated cholestasis (PNAC) using a parenteral fish-oil-based lipid. Clin Nutr. 2009 ; 28: 209-212
32. Aragon G, Younossi ZM. When and how to evaluate mildly elevated liver enzymes in apparently healthy patients. Clev Clin J Med. 2010 ; 77: 1995-1204
33. Hung YL, Chen PC, Jeng SF, et al. Serial measurements of serum alkaline phosphatase for early prediction of osteopenia in preterm infants. J Paediatr Child Health. 2011 ; 47: 134-139
34. Cabrera-Abreu JC, Green A. Gamma-glutamyltransferase: value of its measurement in paediatrics. Ann Clin Biochem. 2002 ; 39: 22-25
35. Backström MC, Kouri T, Kuusela AL, et al. Bone isoenzyme of serum alkaline phosphatase and serum inorganic phosphate in metabolic bone disease of prematurity. Acta Paediatr. 2000 ; 89: 867-873
36. Ashmeade T, Pereda L, Chen M, Carver JD. Longitudinal measurements of bone status in preterm infants. J Pediatr Endocrinol Metab. 2007 ; 20: 415-424
37. Mitchell SM, Rogers SP, Hicks PD, Hawthorne KM, Parker BR, Abrams SA. High frequencies of elevated alkaline phosphatase activity and rickets exist in extremely low birth weight infants despite current nutritional support. BMC Pediatr. 2009 ; 9 ( 47 ):
38. Lothe A, Sinn J, Stone M. Metabolic bone disease of prematurity and secondary hyperparathyroidism. J Paediatr Child Health. 2011 ; 47: 550-553
39. Rack B, Lochmüller EM, Janni W, et al. Ultrasound for the assessment of bone quality in preterm and term infants. J Perinatol. 2012 ; 32: 218-226
40. Aiken CG, Sherwood RA, Lenney W. Role of plasma phosphate measurements in detecting rickets of prematurity and in monitoring treatment. Ann Clin Biochem. 1993 ; 30: 469-475
41. Puntis JWL, Rushton DI. Pulmonary intravascular lipid in neonatal necropsy specimens. Arch Dis Child. 1991 ; 66: 26-28
42. Cotogni P, Muzio G, Trombetta A, Ranieri VM, Canuto RA. Impact of the ω-3 to ω-6 polyunsaturated fatty acid ratio on cytokine release in human alveolar cells. JPEN J Parenter Enteral Nutr. 2011 ; 35: 114-121
43. D'Ascenzo R, D'Egidio S, Angelini L, et al. Parenteral nutrition of preterm infants with a lipid emulsion containing 10% fish oil: effect on plasma lipids and long-chain polyunsaturated fatty acids. J Pediatr. 2011 ; 159: 33 e1-38